133 related articles for article (PubMed ID: 31944614)
41. AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema.
Maeda H; Kikura-Hanajiri R; Kawamura M; Nagashima E; Yoshida KI
Clin Toxicol (Phila); 2018 Feb; 56(2):143-145. PubMed ID: 28707493
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples.
Hess C; Murach J; Krueger L; Scharrenbroch L; Unger M; Madea B; Sydow K
Drug Test Anal; 2017 May; 9(5):721-733. PubMed ID: 27400642
[TBL] [Abstract][Full Text] [Related]
43. Quantification of Major Metabolites of AB-FUBINACA in Solid Tissues Obtained from an Abuser.
Minakata K; Hasegawa K; Nozawa H; Yamagishi I; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
J Anal Toxicol; 2021 Jul; 45(6):555-565. PubMed ID: 32886766
[TBL] [Abstract][Full Text] [Related]
44. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.
Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T
Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766
[TBL] [Abstract][Full Text] [Related]
45. Synthetic Cannabinoid and Mitragynine Exposure of Law Enforcement Agents During the Raid of an Illegal Laboratory - Nevada, 2014.
Tapp L; Ramsey JG; Wen A; Gerona R
MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1291-1294. PubMed ID: 29190268
[TBL] [Abstract][Full Text] [Related]
46. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
[TBL] [Abstract][Full Text] [Related]
47. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
Erratico C; Negreira N; Norouzizadeh H; Covaci A; Neels H; Maudens K; van Nuijs AL
Drug Test Anal; 2015 Oct; 7(10):866-76. PubMed ID: 25865117
[TBL] [Abstract][Full Text] [Related]
48. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
[TBL] [Abstract][Full Text] [Related]
49. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
[TBL] [Abstract][Full Text] [Related]
50. Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System.
Cannaert A; Franz F; Auwärter V; Stove CP
Anal Chem; 2017 Sep; 89(17):9527-9536. PubMed ID: 28771321
[TBL] [Abstract][Full Text] [Related]
51. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
[TBL] [Abstract][Full Text] [Related]
52. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
Fraser AD; Worth D
Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292
[TBL] [Abstract][Full Text] [Related]
53. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
[TBL] [Abstract][Full Text] [Related]
54. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
[TBL] [Abstract][Full Text] [Related]
55. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
[TBL] [Abstract][Full Text] [Related]
56. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
Scheidweiler KB; Jarvis MJ; Huestis MA
Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
[TBL] [Abstract][Full Text] [Related]
57. Enantioseparation of the carboxamide-type synthetic cannabinoids N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide and methyl [1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-valinate in illicit herbal products.
Doi T; Asada A; Takeda A; Tagami T; Katagi M; Kamata H; Sawabe Y
J Chromatogr A; 2016 Nov; 1473():83-89. PubMed ID: 27773389
[TBL] [Abstract][Full Text] [Related]
58. Discovery of Orexant and Anorexant Agents with Indazole Scaffold Endowed with Peripheral Antiedema Activity.
Dimmito MP; Stefanucci A; Pieretti S; Minosi P; Dvorácskó S; Tömböly C; Zengin G; Mollica A
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31527522
[TBL] [Abstract][Full Text] [Related]
59. Identification and Quantification of 5-Fluoro ADB and the 5-Fluoro ADB Ester Hydrolysis Metabolite in Postmortem Blood Samples by LC-MS/MS.
Seither JZ; Reidy LJ; Boland DM
J Anal Toxicol; 2020 Mar; 44(2):133-139. PubMed ID: 31274144
[TBL] [Abstract][Full Text] [Related]
60. Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.
Canazza I; Ossato A; Vincenzi F; Gregori A; Di Rosa F; Nigro F; Rimessi A; Pinton P; Varani K; Borea PA; Marti M
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
